chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Petechiae; Immediately developed a rash on left side in the stomach area; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 79-year-old male patient received BNT162b2 (BNT162B2), on 25Feb2021 at 10:30 as dose 1, single (Lot number: EN6200) at the age of 79 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: IBUPROFEN. The following information was reported: RASH (non-serious) with onset 25Feb2021, outcome "not recovered", described as "Immediately developed a rash on left side in the stomach area"; PETECHIAE (non-serious) with onset 27Feb2021, outcome "not recovered". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of petechiae, rash.  Additional information: After the first injection in 25Feb2021, patient immediately developed a rash on left side in the stomach area. To this day, the rash, petechiae, is still present. Other medications the patient received within 2 weeks of vaccination included Vitamin Daily and Ibuprofen. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient tested for COVID-19 as negative. Patient had no known allergies. Patient received dose 2 of BNT162B2 (lot number: ER2613) on 18Mar2021 at 09:15 AM in the Right arm. Patient received Dose 3 of BNT162B2 (lot number: EWO175) on 01Nov2021 at 10:00 AM, in the Left arm.
This spontaneous report as received from a nurse refers to an unspecified number patients of unknown age and gender. On an unknown date in 2014 (reported as since 08-AUG-2014), the patients were vaccinated with (Oka/Merck) VARIVAX which was improperly stored, (strength, dose, lot numbers and route were not reported). No adverse effects were reported. Follow up information has been received from the registered nurse who stated that it will take some time to get the (Oka/Merck) VARIVAX information (patient identifiers, lot numbers, expiration dates and dates of vaccination administration) together and that she may send the information at a later time. Follow up information has been received from the registered nurse concerning a patient (age range reported as 6-12, units not reported) of unknown gender. On 01-OCT-2014, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX which was improperly stored (lot number K005180, expiration date 10-APR-2016; dose number, dose and route were not reported). The reporter stated that this was the information that they could find and provide and anything further would be much too difficult and time consuming due to their record keeping and tracking system. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
Both my husband and I had a slight metallic taste after both shots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Feb2021 13:00 (Lot number: EN 5318) at the age of 72 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "multiple allergies" (unspecified if ongoing). Concomitant medication(s) included: PROPRANOLOL; CRESTOR; VIT D. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EL1283, administration time=10:30 AM, vaccine location=Right arm, dose number=1), administration date: 08Jan2021, when the patient was 72 years old, for COVID-19 immunisation, reaction(s): "metallic taste". The following information was reported: DYSGEUSIA (non-serious) with onset 05Feb2021 13:15, outcome "recovered" (2021), described as "Both my husband and I had a slight metallic taste after both shots". Therapeutic measures were not taken as a result of dysgeusia.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021251348 Same product and event, different patient
I received my 2nd Covid vaccine (Moderna) on Tues 2/16. On Wednesday my left knee (the last the replacements) was very sore and felt weak. On Thursday the knee didn't get any worse but my lower back and shoulders were sore. On Friday, there wasn't much change. On Saturday the knee seemed to stabilize and the back and shoulders were tolerable. On Sunday, my stomach was queasy. On Monday, sore joints and queasy stomach. On Tuesday, sore joints especially anything injured back in time, diarrhea started. On Wednesday upset stomach, just a piece of toast to eat, diarrhea, chills, sore joints everywhere, miserable. Thursday was the same as Wednesday plus I vomited twice in the evening with sweats and a 101.1 temperature which went back down. I was miserable. I slept well last night and feel better this morning. The diarrhea seems be abating. I feel like I've turned the corner this morning but wanted to mention due to the vaccine shot as a possible cause.
Atrial Flutter diagnosis; Increased heart rate; Itchy warm arm; A spontaneous report was received from a consumer concerning a 93-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced atrial flutter diagnosis, itchy warm arm, increased heart rate.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.  On 19 Jan 2021, 8 days after the vaccination, the patient's arm started to feel itchy and warm, also had an increased heart rate. The patient went to a Cardiologist and diagnosed with Atrial Flutter.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events were unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: syncope and tonic presentation for 5-10 seconds, increased pulse and decreased blood pressure-Severe, Systemic: Hypotension-Mild, Systemic: Shakiness-Medium, Systemic: Tachycardia-Mild, Systemic: Weakness-Medium, Additional Details: paramedics called and within 15 minutes patient was able to stand, sit and speak normally and her color had come back. BP and pulse normalized and after 30 minutes of observation by RPh and paramedic was walked out of store by paramedic.
Full dose of Moderna given when patient was supposed to receive booster. Patient monitored for 30 minutes, no adverse reactions noted. EAU provided to patient to self monitor.
11/25/2022 I had a scratchy throat, slight cough, and fatigue. Morning of 11/26, I took an at home rapid COVID-19 test, which was positive. I began taking TYLENOL and THERAFLU. Doctor's office performed another rapid COVID-19 test, positive. Doctor prescribed PAXLOVID. Symptoms no worse than a cold. O2 Saturation dipped to lowest point at 95% this day. 11/27/2022 I had a headache and muscle aches in shoulders and neck. I had chills and very cold hands. Profuse sweating, I had a fever spiking at 102.2 F. Slept most of the day 11/27 and had to urinate every hour. 11/28, fever broke, Oxygen saturation was back to normal level. Cough continues, occasional sneeze, but no aches or sweating. Still feeling fatigue.
None. Patient vaccinated with 0.25 mL of FLULAVAL QUADRIVALENT vaccine. Vaccine only licensed for 3 years old & older.
Systemic: Shakiness-Moderate, Systemic: muscle spasms/ twitches-Moderate, Additional Details: pt also c/o head felt like flashes of electricity, lightning.  pt was alittle disoriented after recovered from muscle spasm/twitch.  pt A & O and left clinic ambulatory.  pt waited for a total of 1 hour after vaccine was given, additional 45 mins.  was added to wait time post administration.  pt instructed to inform PCP re vaccine reaction.  pt presented to clinic highly anxious, per pt did take daily dose of valium prior to coming to clinic for vaccine.
CHILLS; FEVER; This spontaneous report received from a patient concerned an adult female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number.  No concomitant medications were reported. On an unspecified date, the subject experienced chills, and fever. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine was not applicable. The patient recovered from chills, and fever. This report was non-serious.
Severe Tinnitus, slight hearing loss, accompanying  severe headache - tinnitus has persisted for three weeks, unabated.
Left arm swelling, redness, warm to touch, soreness (describes as "caked-feeling" (hardness) under the redness).  Gave shot 11/07/2006 approximately 2 pm-adverse effects started next morning on 11/08/2006 (area effected starts about 3 inches below shot area and goes down arm another 4 to 5 inches) as of 11/10/2006, still experiencing side effects but still have lessened due to BENADRYL. Patient also states diarrhea and nauseated starting next morning.
Shortly after receiving the vaccine, Client complained of lightheadedness.  She noticed it when she started to get up to leave as she had sat there for 30 minutes.  She does admit to having some anxiety about getting the shot as she has had an anaphylaxis reaction to both pyridium and macrobid requiring ED intervention.  She carries an epipen with her.  She is on Metoprolol as she throws quite a few PVCs.  BP at 11:55 am 186/88- pulse-64 and ox reading 97%.  Encouraged to drink some water to hydrate as has not drank much today.  BP at 12:05 pm BP=184/84 and light headedness has resolved and able to leave.  Card with contact information given to Client if any other side effect should be experienced.  Encouraged her
The pt experienced a fever and was hospitalized on 8/22/01 to 8/24/01.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 ml. On 16-Sep-2021 at 9:16 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 ml. On 16-Sep-2021 at 9:16 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 16-Sep-2021 at 9:16 AM, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment details were not given.   This case was linked to MOD-2021-405653, MOD-2021-399960 (Patient Link).
Approximately 5 minutes after receiving shot patient passed out while sitting in chair during monitoring period, she slid to the floor and woke up after a few seconds. Her mom helped her sit back in her chair and then another minute later she passed out again and her head dropped to the table in front of her. Her mom and I sat her upright and she regained consciousness a few seconds later again. The mother declined emergency services for her. We continued to monitor her for 30 minutes and then she left with her mom without further issue.
10/02/99 -Onset of local soreness, Aching from shoulder to elbow, lasting 10 days; 10/04/99 -Rash along waist line, Lasting6 weeks
A 35 year old reported experiencing chronic fatigue, psychological and sleep disorders, GI distress, fibromyalgia, and muscle pain following immunization with BioThrax. In 2003, when he was 21 years of age prior to going to overseas, he received BioThrax vaccine series. The consumer indicated that his symptoms were persistent. Additional information has been requested.
Sunday, March 14th, noticed red itchy bumps on back of left leg.  Tuesday, March16th, noticed red bumps on chest and stomach, immediately following a run.  Wednesday, March 17th, noticed red bumps on chest, stomach, back, groin, arms, and neck.  Thursday, March 18th, no change red bumps appear to be spreading.  Friday, March 19th, red bumps appear to be spreading and more prevalent in left groin area, bumps appear to be travelling down left arm towards direction of left hand.  Bumps are not that itchy, but do have an occasional itchiness on a scale of 1 to 10, about a 1 or 2 with itch.  Per the recommendation of Urgent Care, I am taking Benadryl, but only taking one pill at night before bedtime and there appears to be no improvement.
Information has been received from a registered nurse concerning a 1 day old male patient whose mother was exposed to GARDASIL during pregnancy. It was reported that the patient was born, weight 6 lb 5.9 oz, APGAR (Appearance, Pulse, Grimace, Activity, Respiration.) score 8/9. The baby experienced intrauterine growth retardation and umbilical mass (also reported infant normal). At the time of the report, the patient's outcome was unknown. Upon internal review, umbilical mass was considered to be a congenital anomaly. The mothers experience has been reported in WAES # 0912USA01991. Additional information has been requested.
My back is like broken or something; I have many allergic reaction from vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 23Dec2021 (Lot number: FF2593) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK INJURY (non-serious) with onset 26Dec2021, outcome "unknown", described as "My back is like broken or something"; HYPERSENSITIVITY (non-serious) with onset 26Dec2021, outcome "unknown", described as "I have many allergic reaction from vaccine".   No follow-up attempts are needed. No further information is expected.
Shortness of breath, a little tightening; Some swelling in face, looks a little swollen; Headache; Uncomfortable in her chest/Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Uncomfortable in her chest/Chest pain), DYSPNOEA (Shortness of breath, a little tightening), SWELLING FACE (Some swelling in face, looks a little swollen) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cardiac disorder (she has 16 stents.). Concomitant products included fibromyalgia for Fibromyalgia.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced CHEST PAIN (Uncomfortable in her chest/Chest pain). On an unknown date, the patient experienced DYSPNOEA (Shortness of breath, a little tightening), SWELLING FACE (Some swelling in face, looks a little swollen) and HEADACHE (Headache). The patient was treated with NITROGLYCERIN for Chest pain, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (Uncomfortable in her chest/Chest pain), DYSPNOEA (Shortness of breath, a little tightening), SWELLING FACE (Some swelling in face, looks a little swollen) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Information has been received from a registered nurse concerning a 10 year old male who on 19-MAR-1998 was vaccinated in the left thigh with a first dose of VARIVAX (Oka/Merck) (Lot#625050/1610E).  Illness at the time of vaccination included right otitis media, an upper respiratory tract infection and constipation.  On 23-JUL-2007 the patient developed 1 lesion on the mid right abdomen after varicella exposure to his brother.  Medical attention was sought and the doctor prescribed acyclovir 800mg twice a day for 5 days.  On 30-AUG-2007 the patient recovered.  No further information was provided.  The reporter considered the patient's experience to be an other important medical event since medication was prescribed.  Additional information is not expected.  This is one of several reports from the same source. Follow-uo information from the reporting registered nurse indicated that this patient was vaccinated with the first dose of VARIVAX (Oka/Merck) (Lot# 625050/1610E) on 19-MAR-1998 and then the patient's brother was vaccinated (WAES# 0709USA03365). This patient was the first to experience the lesion on the mid right abdomen and then his brother developed 2 lesions on his abdomen and 1 lesion on his upper leg. The reporter stated there was no mention of an exposure to VZV WILD TYPE STRAIN virus in the patient's chart. The patient recovered, it was noted that there were on reoccurrences of the event. Additional information is not expected.  This is one of several reports from the same source.
My lymphnodes in my armpit on the side of my injection have swollen to an uncomfortable size and are a little painful.
42 Y female who presents with left arm swelling and red streak progressing up to her left neck.  Symptoms began after receiving a pneumococcal and Adacel vaccination in her left deltoid 3 days ago.  Having worsening left arm pains today.  Also feels a tender lymph node at her left clavicle.  She was prescribed doxycycline by telephone but has not started yet.
Patients administered Moderna vaccine while temperature excursion assessment was ongoing; Patients administered Moderna vaccine while temperature excursion assessment was ongoing; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) and EXPIRED PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) and EXPIRED PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) and EXPIRED PRODUCT ADMINISTERED (Patients administered Moderna vaccine while temperature excursion assessment was ongoing) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because her facility was unable to download the digital data, they would need to treat this issue as a temperature excursion. The data was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at this time. It was reported that no adverse reactions were reported by any patients.  No treatment medication was provided.
Case number PHEH2015US019672, is a combined initial and follow-up spontaneous report from a nurse received on 01 Oct 2015 and on 02 Oct 2015. This report refers to a 38 year old female patient. Past medical history and concomitant medications were not reported. Nurse reported that the patient was vaccinated with expired FLUVIRIN (batch number: 1413801, expiry date: Jun 2015) 0.5 ml intramuscular on 30 Sep 2015. No adverse event was reported. No further information was provided.
Fainted; This is a spontaneous report from a contactable consumer (patient). A 17-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 07Apr2021 15:30 (at the age of 17years) as single dose for Covid-19 immunization. The patient is not pregnant at the time of vaccination. Medical history included asthma, pediatric Kawasaki disease from 2006 to an unknown date, known allergies: Sulfa drugs, and Covid-19 from an unknown date and unknown if ongoing (Covid prior vaccination: Yes). Concomitant medications included sertraline hydrochloride (ZOLOFT) and ethinylestradiol, ferrous fumarate, norethisterone acetate (BLISOVI FE 1/20), both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the patient fainted the following morning on 08Apr2021 10:00. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of event was recovering.  Information on the lot/batch number has been requested.
Vaccines given 03/09/05. Child seen 03/11/05, for rash and swelling below injection site on left anterior thigh. Treated with Benadryl and ice.
Shingrex vaccine given by pharmacist in right arm.  Painful initially then within a few days after the injection my right arm and hand seemed to be developing lymphedema, and some pain right wrist.  My fingers were all swollen to point of had difficulty removing  ring from right ring finger, arm also swollen all the way up to axilla.  There was pitting on awakening that took a few hours to lessen.   My hand and arm are pretty much the same now.
Patient was given the child vaccine from ages 5-11 y/o and the patient is 13 years old  0.3  ml
Child woke up 9/14/16 around 0100 AM with skin itching - described rash that was red and small bumps at time. States there was swelling to right eye and lips. Visit to office on 9/14/16 with mild lip swelling, no eye swelling, and no visible rash. Symptoms improved with BENADRYL.
rt arm became swollen, red, hot 2" diameter by later afternoon of 15OCT96;purple-1' center;felt flu sx (fever, weak, fatigue, h/a);t101-102 16OCT96;APAP used 15OCT95-16OCT96;advised to use ice/cold compresses @ site & call pvt MD;
Information has been received from a physician concerning a 10 year old female with no pertinent medical history, drug reactions or allergies who on 07-SEP-2007 was vaccinated intramuscularly with a second dose , 0.5 mL, of varicella virus vaccine live (Oka/Merck) (lot # 658194/1095U). There was no concomitant medication. On approximately 08-SEP-2007, within 24 hours of receiving the vaccine, the patient developed erythema, soreness, pruritus and a rash at the injection site. The patient was diagnosed with cellulitis and treatment with cephalexin (Keflex). No lab diagnostic tests were performed. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.